nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults, paralleling the epidemic of obesity and diabetes and leading to worrisome events (hepatocellular carcinoma and end-stage liver disease). In the past years, mounting evidence added insights about epidemiology, natural history, diagnosis and lifestyle-based or drug treatment of NAFLD. In this rapidly evolving scenario, members of the associazione Italiana per lo studio del fegato, the societa Italiana di diabetologia and the societa Italiana dell'obesita reviewed current knowledge on NAFLD. the quality of the published evidence is graded, and practical recommendations are made following the rules and the methodology suggested in Italy by the centro nazionale per l'enccellenza delle cure and Istituto superiore di sanita. whenever possible, recommendations are placed within the context the Italian Healthcare system, with reference to specific experience and local diagnostic and management resources.
Marchesini, G., Bugianesi, E., Burra, P., Marra, F., Miele, L., Alisi, A., et al. (2021). Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). EATING AND WEIGHT DISORDERS, 27(5), 1603-1619 [10.1007/s40519-021-01287-1].
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
Federici, M.Membro del Collaboration Group
;
2021-01-01
Abstract
nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults, paralleling the epidemic of obesity and diabetes and leading to worrisome events (hepatocellular carcinoma and end-stage liver disease). In the past years, mounting evidence added insights about epidemiology, natural history, diagnosis and lifestyle-based or drug treatment of NAFLD. In this rapidly evolving scenario, members of the associazione Italiana per lo studio del fegato, the societa Italiana di diabetologia and the societa Italiana dell'obesita reviewed current knowledge on NAFLD. the quality of the published evidence is graded, and practical recommendations are made following the rules and the methodology suggested in Italy by the centro nazionale per l'enccellenza delle cure and Istituto superiore di sanita. whenever possible, recommendations are placed within the context the Italian Healthcare system, with reference to specific experience and local diagnostic and management resources.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
